Biophytis Announces New Scientific Advisory Board for its Phase 2 OBA Clinical Study in Obesity
| BPTSDelisted Stock | USD 7.03 0.00 0.00% |
Slightly above 56% of Biophytis' investor base is looking to short. The analysis of current outlook of investing in Biophytis suggests that many traders are alarmed regarding Biophytis' prospects. Biophytis' investing sentiment can be driven by a variety of factors including economic data, Biophytis' earnings reports, geopolitical events, and overall market trends.
Biophytis |
IND to be filed with the FDA in the coming weeksPARIS, FRANCE and CAMBRIDGE, MA ACCESSWIRE April 18, 2024 Biophytis SA , ,
Read at accesswire.com
 |
Biophytis Fundamental Analysis
We analyze Biophytis' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Biophytis using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Biophytis based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Earnings Per Share
Earnings Per Share Comparative Analysis
Biophytis is currently under evaluation in earnings per share category among its peers. Earnings per Share (EPS) denotes the portion of a company's earnings that is allocated to each share of common stock. To calculate Earnings per Share investors will need to take a company's net income, subtract any dividends for preferred stock, and divide it by the number of average outstanding shares. EPS is usually presented in two different ways: basic and diluted. Fully diluted Earnings per Share takes into account effects of warrants, options, and convertible securities and is generally viewed by analysts as a more accurate measure.
Biophytis Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Biophytis stock to make a market-neutral strategy. Peer analysis of Biophytis could also be used in its relative valuation, which is a method of valuing Biophytis by comparing valuation metrics with similar companies.
Peers
Biophytis Related Equities
| NRXPW | NRx Pharmaceuticals | 30.43 | ||||
| SPRO | Spero Therapeutics | 9.64 | ||||
| TPST | Tempest Therapeutics | 3.33 | ||||
| HCWB | HCW Biologics | 2.78 | ||||
| RZLT | Rezolute | 2.31 | ||||
| IPHA | Innate Pharma | 1.20 | ||||
| ARMP | Armata Pharmaceuticals | 0.98 | ||||
| INBX | Inhibrx | 0.37 | ||||
| XOMAO | XOMA | 0.39 | ||||
| AKTX | Akari Therapeutics | 0.83 | ||||
| ANEB | Anebulo Pharmaceuticals | 1.85 | ||||
| BOLT | Bolt Biotherapeutics | 1.92 | ||||
| CHRS | Coherus BioSciences | 2.11 | ||||
| PTIX | Protagenic Therapeutics | 2.22 | ||||
| NRXP | NRX Pharmaceuticals | 5.87 | ||||
| PCSA | Processa Pharmaceuticals | 6.90 |
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate. You can also try the Price Exposure Probability module to analyze equity upside and downside potential for a given time horizon across multiple markets.
Other Consideration for investing in Biophytis Stock
If you are still planning to invest in Biophytis check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Biophytis' history and understand the potential risks before investing.
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm |